Pharmaceutical Gelatin Market Report 2026

Pharmaceutical Gelatin Market Overview

• Pharmaceutical Gelatin market size has reached to $1.37 billion in 2025 • Expected to grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Pharmaceutical Gelatin Market Surges with Rising Demand in the Thriving Health and Wellness Industry • Market Trend: Revolutionizing Softgel Production Easyseal Gelatin Introduces Advanced Solution • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pharmaceutical Gelatin Market?

Pharmaceutical gelatin is a type of gelatin that is specifically produced for use in medications and medical applications. It is made from collagen, a protein found in animal connective tissues, and is highly purified to meet strict safety and quality standards. It is used to provide a good barrier to light, moisture, and oxygen. The main types of pharmaceutical gelatin are type A and type B. Type A refers to gelatin that is produced using the acid method, which involves the hydrolysis of collagen in the presence of an acid. It has various functions such as stabilizing agent, thickening agent, gelling agent, and other functions, it includes sources such as porcine, bovine skin, bovine bone, marine, and poultry. These are used in hard capsules, soft gel capsules, tablets, absorbable hemostats, others.

What Is The Pharmaceutical Gelatin Market Growth Forecast?

The pharmaceutical gelatin market size is expected to see strong growth in the next few years. It will grow to $1.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to expanding pharmaceutical applications, rising demand in emerging markets, technological advancements in gelatin extraction, increased adoption in nutraceuticals, innovation in alternative gelatin sources. Major trends in the forecast period include increasing demand for hard and soft gel capsules, rising adoption of pharmaceutical gelatin in absorbable hemostats, growth in bovine and porcine gelatin production, expansion of marine and poultry gelatin sources, stringent regulatory compliance and quality standards.

Global Pharmaceutical Gelatin Market Segmentation

1) By Type: Type A, Type B 2) By Function: Stabilizing Agent, Thickening Agent, Gelling Agent & other function 3) By Source: Porcine, Bovine Skin, Bovine Bone, Marine, Poultry 4) By Application: Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, Other Applications Subsegments: 1) By Type A: Porcine Gelatin, Bovine Gelatin 2) By Type B: Bovine Gelatin, Fish Gelatin

What Is The Driver Of The Pharmaceutical Gelatin Market?

The increasing demand for health and wellness is expected to propel the growth of the pharmaceutical gelatin market going forward. Health and wellness are terms that encompass a holistic approach to overall well-being, incorporating physical, mental, and social aspects of health. Pharmaceutical gelatin is used in health and wellness to deliver medications safely and effectively by improving the effectiveness of some medications and reducing the need for frequent dosing. For instance, in January 2024, according to Wellness Creative Co, a UK-based wellness company, the health and wellness sector is expected to reach $7.2 trillion by 2025, growing at an annual rate of 8.5%. Therefore, the increasing demand for health and wellness is driving the growth of the pharmaceutical gelatin industry.

Key Players In The Global Pharmaceutical Gelatin Market

Major companies operating in the pharmaceutical gelatin market are Nitta Gelatin Inc., Lonza Group AG, Darling Ingredients Inc., Catalent Inc., Tessenderlo Group NV, Gelita AG, Rousselot Inc., Weishardt & Co. KG, Batotau Dongbao Bio-Tech, Nippi Collagen Co. Ltd., Apex Pharma Ltd., Narmada Gelatines Ltd., Aspire Pharmaceuticals Pvt. Ltd., Sterling Gelatin Limited, Junca Gelatines SL, Trobas Pharmaceutical gelatine B.V., Gelco International, Reichert Gruppe Ingredients GmbH, Norland Products Inc., Lapi Gelatine S.p.a., Italgelatine S.p.A, Kenney & Ross Limited, Xiamen Yasin industry & Trade Co. Ltd., PB Gelatins SA

Global Pharmaceutical Gelatin Market Trends and Insights

Major companies operating in the pharmaceutical gelatin market are introducing advanced solutions such as, Easyseal gelatin to reduce the production costs associated with soft gel leakers. Easy seal resolves the issue as its solution incorporates optimized seam forming and enhanced seam thickness and stability, making soft capsules more resilient to physical stress and mitigating the problem of leakers. For instance, in December 2023, GELITA MEDICAL GmbH, a Germany-based manufacturer of gelatin and collagen peptides for the food, health, and nutrition pharmaceutical industries, launched Easyseal gelatin. The innovation exhibits reduced dependency on sealing temperature compared to other gelatins and boasts superior drying properties. It helps enhance energy efficiency and also improves overall production capacity. The new product empowers manufacturers to reliably seal capsules at high speeds, especially with suspensions that are typically challenging to fill. It proves particularly beneficial in the creation of products requiring special equipment, such as double-step die tooling.

What Are Latest Mergers And Acquisitions In The Pharmaceutical Gelatin Market?

In April 2023, Darling Ingredients Inc., a US-based manufacturer of animal food, acquired Gelnex Gelatin for an undisclosed amount. Through this acquisition, Darling Ingredients gains immediate production capacity to meet the growing demands of its collagen customers and is well-positioned to serve the expanding demand for gelatin and collagen. Gelnex Gelatin is a Brazil-based manufacturer of gelatin and collagen products for pharmaceutical gelatin.

Regional Insights

North America was the largest region in the pharmaceutical gelatin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pharmaceutical Gelatin Market?

The pharmaceutical gelatin market consists of sales of pharmaceutical gelatin sourced from cattle bones, natural and marine sources gelatin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pharmaceutical Gelatin Market Report 2026?

The pharmaceutical gelatin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical gelatin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.